https://www.selleckchem.com/pr....oducts/crenolanib-cp
I forms an important role in ensuring adequate treatment planning to improve outcomes, decreasing morbidity, and improve functional outcomes. Olfactory dysfunction related to SARS-CoV-2 infection and COVID-19 disease is now well established in the literature. In December 2020, the FDA approved the Pfizer-BioNTech and Moderna vaccines for use in preventing COVID-19 in the United States. To the best of our knowledge, this is the first report of a phantosmia post-Pfizer COVID-19 vaccination, with positive magnetic resonance im
Curtir
Comentario
Compartilhar
